Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01EB029455-02
Immunoengineered nanotechnology for targeted expansion of regulatory T cells
National Institutes of Health
Grant: 1U01AI148119-01
Mapping the effector response space of antibody combinations
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-BIO/29266/2017
Deep Drug Discovery and Deployment
National Institutes of Health
Grant: 5R01AI041158-04
IMMUNOPATHOGENESIS OF TOXOPLASMIC ENCEPHALITIS
National Institutes of Health
Grant: 5K99CA246061-02
Developing strategies to inhibit cancer immunotherapy-induced immune-related adverse events without impeding anti-tumor immunity
National Institutes of Health
Grant: 5R01AI125563-05
Impact of early T-bet on CD8 T cell effector responses
Fields of Study
Keywords
Sustainable Development Goals